David A. Siegel Ocular Therapeutix, Inc Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q3 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Two Sigma Advisers, LP holds 10,400 shares of OCUL stock, worth $91,312. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,400
Previous 37,300
72.12%
Holding current value
$91,312
Previous $255,000
64.71%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding OCUL
# of Institutions
172Shares Held
138MCall Options Held
150KPut Options Held
225K-
Summer Road LLC West Palm Beach, FL14.4MShares$126 Million98.8% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$112 Million11.5% of portfolio
-
Deep Track Capital, LP Greenwich, CT12.7MShares$112 Million4.08% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$101 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.38MShares$73.6 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $676M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...